Announced Mon, 13 Jul · 14:28 IST
Routine SEBI compliance filing on share dematerialisation for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.8%1-day move
₹28.80
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.8-2.1+1.5+0.7-2.6-6.2————
Up moveDown movePending
AI summary
Prism Medico and Pharmacy submitted a quarterly confirmation certificate from its registrar Purva Sharegistry under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The filing confirms processing of dematerialisation requests. No share certificates were dematerialised during 1 April to 30 June 2026. The company is listed on BSE (512217) and MSEI (PRISMMEDI).
Likely market impact
Routine compliance filing with no material business or price impact. No dematerialisation activity during the quarter.